Skip to main content

What the label lists and what reports show

Sodium ferric gluconate complex side effects

Sodium ferric gluconate complex's FDA label: “The most commonly reported adverse reactions (≥10%) in adult patients were nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain.” FAERS holds 2,153 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is nausea (510 reports).

  • Generic listed

Check it at the source: the sodium ferric gluconate complex FDA label on DailyMed (effective October 7, 2025, sanofi-aventis U.S. LLC); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The most commonly reported adverse reactions (≥10%) in adult patients were nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain.

From the label: adverse reactions, continued

The following clinically significant adverse reactions are discussed in greater detail in other sections of the labeling: Hypersensitivity [see Contraindications (4) and Warnings and Precautions (5.1) ] Hypotension [see Warnings and Precautions (5.2) ] The most commonly reported adverse reactions (≥10%) in adult patients were nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain. In patients 6 to 15 years of age the most common adverse reactions (≥10%) were hypotension, headache, hypertension, tachycardia and vomiting. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact sanofi-aventis U.S. LLC at 1-800-633-1610 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. The most commonly reported adverse reactions (≥10%) in adult patients were nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, abnormal erythrocytes (e.g., changes in morphology, color, or number of red blood cells), dyspnea, chest pain, leg cramps and pain. …

Source: FDA drug label, sanofi-aventis U.S. LLC, effective October 7, 2025 (SPL set b25b34ab-9cf1-4a2b-bdf2-5eaf66625999), via openFDA; the full label on DailyMed

What do FAERS reports show?

2,153 reports list sodium ferric gluconate complex among the medicines taken, each a report of something that happened, not proof the medicine caused it; 440 are coded as a death and 912 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 23 reactions below, 10 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Nausea (named in the label)510
  • Vomiting (named in the label)455
  • Abdominal Pain (named in the label)407
  • Dyspnoea (named in the label)387
  • Sepsis (named in the label)293
  • General Physical Health Deterioration285
  • Abdominal Distension269
  • Off Label Use (a use or a product term, not a reaction)268
  • Ascites260
  • Hyponatraemia258
  • Multiple Organ Dysfunction Syndrome257
  • Appendicitis256
  • Stress255
  • Appendicolith252
  • Constipation252
  • Cardiogenic Shock251
  • Ventricular Fibrillation222
  • Hypotension (named in the label)210
  • Condition Aggravated (a use or a product term, not a reaction)197
  • Infusion Related Reaction196
  • Somnolence (named in the label)188
  • Anaemia187
  • Swelling (named in the label)181
  • Dry Mouth (named in the label)174
  • Urticaria (named in the label)174

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Sodium ferric gluconate complex: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions